Mike Seganish

Company: Merck & Co

Job title: Senior Principal Scientist & Director - Scientific & Discovery Chemistry

Seminars:

Panel: Learning from Previous ADC Development: What Can we Learn from Previous ADCs That Can Be Applied to Novel ADCs? 3:00 pm

Have we learned any lessons in the development of ADCs that we need to consider when developing novel ADCs? What are the toxicological considerations associated with developing novel ADCs? What are the preclinical and clinical challenges in developing novel ADCs?Read more

day: Day Two